nicorandil has been researched along with Embolus in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, Z; Li, L; Long, M; Qin, Z; Wang, F; Zheng, J | 1 |
| Kong, B; Lv, X; Qin, Z; Su, Q; Sun, Y; Ye, Z | 1 |
2 other study(ies) available for nicorandil and Embolus
| Article | Year |
|---|---|
Nicorandil inhibits cardiomyocyte apoptosis and improves cardiac function by suppressing the HtrA2/XIAP/PARP signaling after coronary microembolization in rats.
Topics: Animals; Anti-Arrhythmia Agents; Aorta; Apoptosis; Apoptosis Regulatory Proteins; Embolism; Female; Inhibitor of Apoptosis Proteins; Male; Myocardial Infarction; Myocardium; Myocytes, Cardiac; Nerve Tissue Proteins; Nicorandil; Poly(ADP-ribose) Polymerase Inhibitors; Rats, Sprague-Dawley; Serine-Arginine Splicing Factors; Signal Transduction | 2021 |
Role of TLR4/MyD88/NF-κB signaling pathway in coronary microembolization-induced myocardial injury prevented and treated with nicorandil.
Topics: Animals; Anti-Inflammatory Agents; Cell Survival; Coronary Stenosis; Cytoprotection; Disease Models, Animal; Embolism; Inflammation Mediators; Interleukin-1beta; Lipopolysaccharides; Male; Microspheres; Myeloid Differentiation Factor 88; Myocardial Infarction; Myocarditis; Myocytes, Cardiac; NF-kappa B; Nicorandil; Rats, Sprague-Dawley; Signal Transduction; Stroke Volume; Toll-Like Receptor 4; Tumor Necrosis Factor-alpha; Ventricular Dysfunction, Left; Ventricular Function, Left | 2018 |